Results 141 to 150 of about 47,678 (217)

Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer. [PDF]

Signal Transduct Target Ther
Lu J, Hu M, Zhao Y, Chu T, Zhang W, Zhou Y, Cai X, Wu J, Hu L, Shi C, Xiong L, Gu A, Wang H, Zhang Y, Lou Y, Zhong R, Gao Z, Liu H, Zhou C, Wu Y, Zhu L, Zhong H, Ji H, Han B.   +23 more
europepmc   +1 more source

Bis{2-[bis-(2-hy-droxy-eth-yl)amino]-acetato}-zinc(II) monohydrate. [PDF]

IUCrdata
Rakovský E, Valappil LT, Pateda YR, Bartošová L, Chrappová J.   +4 more
europepmc   +1 more source

Tualang honey inhibited H23 human lung adenocarcinoma cell growth by modulating the expression of functional apoptotic proteins

Frontiers in Pharmacology, 2019
Nazirah Amran, Puteri Shafinaz Abdul-Rahman, Hwee-Ming Cheng   +2 more
openaire   +1 more source

The m6A methyltransferase METTL3 affects ferroptosis in non-small cell lung cancer by regulating the PTEN/PI3K/AKT pathway. [PDF]

Discov Oncol
Wu B, Li D, Wang Y, Pan T, Xu J, Li L.
europepmc   +1 more source

Incomplete paralog compensation generates selective dependency on TRA2A in cancer. [PDF]

PLoS Genet
Lee AR, Tangiyan A, Singh I, Choi PS.
europepmc   +1 more source

Mechanistic Insights into NO Releasing by Functionalized Carbon Quantum Dots: A DFT Study. [PDF]

ACS Omega
Souza-Silva HR, Gomes OP, Dionizio JP, Bégué D, Lisboa-Filho PN, Batagin-Neto A.   +5 more
europepmc   +1 more source

Inhibition of mitochondrial complex I induces mitochondrial ferroptosis by regulating CoQH2 levels in cancer. [PDF]

Cell Death Dis
Deng R, Fu L, Liang H, Ai X, Liu F, Li N, Wu L, Li S, Yang X, Lin Y, Huang Y, Yun J.   +11 more
europepmc   +1 more source

Impact of piR_004530 reactivation in lung cancer: implications for recurrence and survival of lung squamous cell carcinoma patients. [PDF]

BMC Med
He Y, Acosta-Plasencia M, Sánchez-Lorente D, Viñolas N, Martinez D, Díaz T, Altuna-Coy A, Na R, Liu Y, Boada M, Guirao A, Molins L, Marrades RM, Navarro A.   +13 more
europepmc   +1 more source

Overcoming BET-inhibitor JQ1 resistance in aggressive non-small cell lung cancer by inducing ferroptosis via inhibition of the BRD2-FTH1 axis. [PDF]

FEBS J
Scicchitano S, Garofalo C, Stella B, Santamaria G, Cozzolino F, Monaco V, Biamonte F, Monti M, Vecchio E, Faniello MC.   +9 more
europepmc   +1 more source

Anlotinib enhances the efficacy of KRAS-G12C inhibitors through c-Myc/ORC2 axis inhibition in non-small cell lung cancer. [PDF]

Cell Death Dis
Liu H, Zhou C, Lu J, Liu Y, Zou P, Zhu L, Lei H, Han B.   +7 more
europepmc   +1 more source